.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Federal Trade Commission
McKinsey
Harvard Business School
AstraZeneca
Cipla
Medtronic
Daiichi Sankyo
Farmers Insurance
Mallinckrodt

Generated: December 13, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: 03100882

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Emd SeronoGONAL-F RFF REDI-JECTfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021684-001May 25, 2004RXYesYes► Subscribe► Subscribe► SubscribeY
Emd SeronoGONAL-F RFF REDI-JECTfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021684-002May 25, 2004RXYesYes► Subscribe► Subscribe► SubscribeY
Emd SeronoGONAL-F RFF REDI-JECTfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021684-003May 25, 2004RXYesYes► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist